Cancer Drugmaker G1 Therapeutics Makes IPO Pitch To Wall Street

April 18, 2017 | Research Triangle Park, NC-based G1 has filed for an initial public offering that could raise up to $115 million. G1 has yet to work out the number of shares it will offer and at what price. Xconomy